# Bladder p75NTR-Mediated Anti-Inflammatory Response via the TLR4/TRAF6/NF-κB Axis

**Authors:** Claudia Covarrubias, Abubakr H. Mossa, Laura R. Yan, Benjamin Desormeau, Philippe G. Cammisotto, H. Uri Saragovi, Lysanne Campeau

PMC · DOI: 10.3390/life15060957 · Life · 2025-06-14

## TL;DR

This study shows that blocking p75NTR can reduce bladder inflammation caused by bacterial infections, potentially offering a new treatment for bladder pain syndrome.

## Contribution

The study identifies p75NTR as a novel therapeutic target for modulating bladder inflammation via the TLR4/TRAF6/NF-κB pathway.

## Key findings

- p75NTR antagonism reduced LPS-induced TNF-α in urothelial cells.
- Blocking p75NTR prevented LPS-induced NF-κB activation and TRAF6 association in smooth muscle cells.
- THX-B injections reduced LPS-induced bladder inflammation in vivo.

## Abstract

Recurrent bacterial cystitis in women can lead to interstitial cystitis or bladder pain syndrome (IC/BPS). Activation of Toll-like receptor 4 (TLR4) by LPS can upregulate signaling of the pro-inflammatory receptor p75NTR. The aim of the presented study was to assess whether p75NTR antagonist THX-B can modulate LPS-mediated inflammation in bladder cells. In vitro expression and LPS-activation of p75NTR were confirmed in urothelial (URO) and smooth muscle (SMC) cells. In UROs, p75NTR antagonism abolished the LPS-elicited rise in membrane-bound and soluble TNF-α. However, it could not prevent LPS-induced rise in phosphorylated ERK nor decrease in phosphorylated p38MAPK, nor the increase in iNOS and nitric oxide (NO) content. On the other hand, in SMCs, LPS increased phosphorylation of JNK, nuclear translocation of NF-κB, and association of TRAF6 to p75NTR, outcomes prevented by p75NTR antagonism. In UROs, LPS decreased the expression of tight junction proteins, ZO-1 and occludin, with the latter rescued by p75NTR antagonism. Intraurethral instillation of LPS increased inflammation in the lamina propria, activation of JNK, and contractile activity of bladder tissue. Alternatively, intraperitoneal THX-B injections prevented LPS-induced inflammation but not enhanced muscle contraction. Our results suggest that inhibition of p75NTR could help in reducing bladder symptoms during cystitis.

## Linked entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099], NGFR (nerve growth factor receptor) [NCBI Gene 4804], TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], TNF (tumor necrosis factor) [NCBI Gene 7124], EPHB2 (EPH receptor B2) [NCBI Gene 2048], P38mapk (p38 map kinase) [NCBI Gene 692545], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], TJP1 (tight junction protein 1) [NCBI Gene 7082], si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3) [NCBI Gene 103182021], MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599]
- **Proteins:** NGFR (nerve growth factor receptor), TLR4 (toll like receptor 4), TRAF6 (TNF receptor associated factor 6), NFKB1 (nuclear factor kappa B subunit 1), TNF (tumor necrosis factor), EPHB2 (EPH receptor B2), P38mapk (p38 map kinase), NOS2 (nitric oxide synthase 2), TJP1 (tight junction protein 1), si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3), MAPK8 (mitogen-activated protein kinase 8)
- **Chemicals:** THX-B (PubChem CID 68352357), nitric oxide (PubChem CID 145068)
- **Diseases:** interstitial cystitis (MONDO:0018301), bladder pain syndrome (MONDO:0018301), cystitis (MONDO:0006032)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189] {aka MGC:3310, RNF85}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ISYNA1 (inositol-3-phosphate synthase 1) [NCBI Gene 51477] {aka INO1, INOS, IPS, IPS 1, IPS-1}, NGFR (nerve growth factor receptor) [NCBI Gene 4804] {aka CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR}
- **Diseases:** IC (MESH:C537984), bladder pain syndrome (MESH:D018856), Inflammatory (MESH:D007249), bacterial cystitis (MESH:D001424), Bladder (MESH:D001745), cystitis (MESH:D003556)
- **Chemicals:** NO (MESH:D009569), THX-B (-), LPS (MESH:D008070)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** URO — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_2743)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12193794/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12193794/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12193794/full.md

---
Source: https://tomesphere.com/paper/PMC12193794